Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by 51c; Lifts Revenue Outlook
Go back to Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by 51c; Lifts Revenue Outlook| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 244.32 -1.53 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.85 | 52 Week High | $160.00 | |||
| Open | $243.59 | 52 Week Low | $95.80 | |||
| Day High | $245.00 | P/E | 45.41 | |||
| Day Low | $240.63 | EPS | $5.38 | |||
| Volume | 212,379 | |||||
